Vincerx Pharma, Inc.
VINCDelisted Apr 28, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001796129
Vincerx Pharma, Inc. was delisted on Apr 28, 2025; its insiders filed their last Form 4 on Aug 14, 2024; 14 institutions reported holding it in 13F filings for Q1 2025, worth $116.8K in total; no superinvestor held it.
Q4 2024 vs. Q3 2024
How the institutions holding Vincerx Pharma, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 26 | 21 | −5 |
| Shares | 11.0M | 4.80M | −6.22M (−56.4%) |
| Value | $7.89M | $1.26M | −$6.63M (−84.0%) |
New holders (2)
Institutions that held Vincerx Pharma, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Colony Group, LLC | 10,900 | $2.87K | 0.00% |
| SBI Securities Co., Ltd. | 1,000 | $263 | 0.00% |
Sold out (7)
Institutions that held Vincerx Pharma, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Prosight Management, LP | 2,206,505 | $1.58M |
| Point72 Asset Management, L.P. | 674,193 | $482.7K |
| ExodusPoint Capital Management, LP | 542,021 | $388.0K |
| Marshall Wace, LLP | 353,562 | $254.6K |
| XTX Topco Ltd | 18,320 | $13.1K |
| Two Sigma Investments, LP | 14,227 | $10.2K |
| Tower Research Capital LLC (TRC) | 6,989 | $5.00K |